You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 6, Issue 1

March 2018 - 16 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (16)

  • Article
  • Open Access
3 Citations
4,846 Views
13 Pages

Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin

  • Marlena M. Westcott,
  • Jason Smedberg,
  • Matthew J. Jorgensen,
  • Shelby Puckett and
  • Douglas S. Lyles

Recombinant vesicular stomatitis virus (VSV) is a promising platform for vaccine development. M51R VSV, an attenuated, M protein mutant strain, is an effective inducer of Type I interferon and dendritic cell (DC) maturation, which are desirable prope...

  • Letter
  • Open Access
10 Citations
8,902 Views
4 Pages

Globally, approximately two billion people are infected with the Hepatitis B virus with attributable death estimated at about half a million people annually across the globe. Chronic hepatitis B infection is also an important public health problem in...

  • Review
  • Open Access
23 Citations
13,908 Views
19 Pages

Since the mid-1980s, two lineages of influenza B viruses have been distinguished. These can co-circulate, limiting the protection provided by inactivated trivalent influenza vaccines (TIVs). This has prompted efforts to formulate quadrivalent influen...

  • Review
  • Open Access
32 Citations
6,767 Views
15 Pages

28 February 2018

Despite a global effort to develop an effective vaccine, malaria is still a significant health problem. Much of the pathology of malaria is immune mediated. This suggests that host immune responses have to be finely regulated. The innate immune syste...

  • Review
  • Open Access
65 Citations
12,778 Views
13 Pages

Meningococcal Vaccines: Current Status and Emerging Strategies

  • Pumtiwitt C. McCarthy,
  • Abeer Sharyan and
  • Laleh Sheikhi Moghaddam

25 February 2018

Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world. There are a number of vaccines (polysaccharide-based, glycoconjugate...

  • Review
  • Open Access
24 Citations
7,547 Views
17 Pages

Virus-Like-Vaccines against HIV

  • Anne-Marie C. Andersson,
  • Melanie Schwerdtfeger and
  • Peter J. Holst

11 February 2018

Protection against chronic infections has necessitated the development of ever-more potent vaccination tools. HIV seems to be the most challenging foe, with a remarkable, poorly immunogenic and fragile surface glycoprotein and the ability to overpowe...

  • Review
  • Open Access
32 Citations
6,792 Views
8 Pages

Radiation and Anti-Cancer Vaccines: A Winning Combination

  • Alexandra Cadena,
  • Taylor R. Cushman,
  • Clark Anderson,
  • Hampartsoum B. Barsoumian,
  • James W. Welsh and
  • Maria Angelica Cortez

30 January 2018

The emerging combination of radiation therapy with vaccines is a promising new treatment plan in the fight against cancer. While many cancer vaccines such as MUC1, p53 CpG oligodeoxynucleotide, and SOX2 may be great candidates for antitumor vaccinati...

  • Review
  • Open Access
39 Citations
10,590 Views
20 Pages

29 January 2018

Declaration of smallpox eradication by the WHO in 1980 led to discontinuation of the worldwide vaccination campaign. The increasing percentage of unvaccinated individuals, the existence of its causative infectious agent variola virus (VARV), and the...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X